Walmart Crashes Most Since 2022 After Huge Comp Store Sales Miss
Walmart's shares fell 9% after Q2 results missed expectations, with US comp sales ex-gas at +2.6% vs. estimates of +3.67%. Adjusted EPS beat at $0.81, while revenue rose 5.9% YoY to $187.94B. Guidance for Q3 and FY2027 missed consensus. The company cited pharmacy deflation and drug price regulations as headwinds. Operating cash flow was $19.7B, with $3B spent on share repurchases.
How this was made
The 30-second read
Why it matters
The earnings miss signals slowing consumer spending and heightened price‑sensitivity, which may affect other big‑box retailers.
Market read
Walmart's disappointing guidance drives a notable price move and may influence sentiment across the retail sector.
What to watch
Potential upside from lower‑price strategy and health‑care cost headwinds easing later in FY27.
Background
Walmart's Q2 comps fell to 2.6% YoY, missing consensus, and guidance for Q3 and FY27 was below estimates, prompting a sharp sell‑off.
Ticker impact
Walmart reported Q2 results with comps miss and guidance below expectations, causing a 9% intraday drop, the largest since July 2022.
Expect additional 3‑5% decline over the next few trading sessions.
The stock fell sharply on the same day of the release; guidance shortfalls are material and the market reaction was immediate.
Market effects
Retail sector may see broader pressure as peers face similar comps challenges.
U.S. consumer‑discretionary stocks could weaken in the near term.
Limited to U.S. large‑cap retail; minimal spillover to non‑U.S. markets.
Counterpoint
If the market overreacts, a pull‑back could set up a short‑term buying opportunity on the dip.
Key entities
- CompanyWalmart
World's largest retailer, ticker WMT.
- ExecutiveJohn David Rainey
CFO of Walmart, provided commentary on health‑wellness impact.
